Adar1 Capital Management, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.06 Trillion distributed in 220 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Abivax Sa with a value of $115B, Keros Therapeutics, Inc. with a value of $85.3B, Protagonist Therapeutics, Inc with a value of $65.7B, Roivant Sciences Ltd. with a value of $50.6B, and Ea Series Trust with a value of $38.4B.
Examining the 13F form we can see an increase of $412B in the current position value, from $652B to 1.06T.
Adar1 Capital Management, LLC is based out at Austin, TX
Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.
Portfolio value
$1.06 Trillion
Healthcare: $648 Billion
ETFs: $83.7 Billion
Communication Services: $996 Million
Consumer Cyclical: $989 Million
Technology: $689 Million
Financial Services: $531 Million
Basic Materials: $312 Million
Stock Holdings Table Market Cap. of $2 Billions to $10 Billions
